Nanopublications

@prefix ns2: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RAKNfDIO1Xe01m9uv4yFXrYrKsbwQiSdPvpK24iqCH4es> .
@prefix sub: <http://purl.org/np/RAKNfDIO1Xe01m9uv4yFXrYrKsbwQiSdPvpK24iqCH4es#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}

sub:assertion {
  sub:association rdf:object <https://identifiers.org/MONDO:0001945> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/CHEBI:2619> ;
    a rdf:Statement ;
    rdfs:label "Amantadine hydrochloride capsules are indicated in the treatment of idiopathic Parkinson’s disease (Paralysis Agitans), postencephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication. It is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis. It is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis." ;
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    bl:has_population_context sub:cohort ;
    bl:provided_by "NeuroDKG" ;
    bl:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=491aea85-5a55-4a7c-b1cf-a123fea4377d> ;
    bl:relation schema:TreatmentIndication .
  sub:cohort rdfs:label "elderly patients" ;
    bl:category bl:Cohort ;
    bl:has_phenotype <https://identifiers.org/MONDO:0006694> .
  <https://identifiers.org/CHEBI:2619> bl:category bl:Drug .
  <https://identifiers.org/MONDO:0001945> bl:category bl:Disease .
}

sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
    npx:hasSignature "GfcBxtx7MYzp1egS6caWpXsTFJ64EuMLYbTXdUEb946btKnvnz+LkRZn3jQMVg/2cOl9zr2vn0EZ4MLbC5LS2XRa2VGxQq7cQw0/5aMjy8zJoSOP0EkMNtZqZz3ldL8UwKhxM1RKPecT5caofdBbZkw/uo+N2bV0at+VdJgn9Pc=" ;
    npx:hasSignatureTarget this: .
  this: ns2:created "2021-03-23T20:10:21.164+01:00"^^xsd:dateTime ;
    ns2:creator orcid:0000-0002-1468-3557 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI> .
}